Henan Lingrui Pharmaceutical Co Ltd
SSE:600285
Henan Lingrui Pharmaceutical Co Ltd
Cash from Investing Activities
Henan Lingrui Pharmaceutical Co Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Henan Lingrui Pharmaceutical Co Ltd
SSE:600285
|
Cash from Investing Activities
-¥436.2m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-9%
|
|
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
Cash from Investing Activities
¥607.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
2%
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Cash from Investing Activities
¥1.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Cash from Investing Activities
-¥2.2B
|
CAGR 3-Years
-94%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-12%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Cash from Investing Activities
-¥188m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
38%
|
CAGR 10-Years
9%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Cash from Investing Activities
¥2.1B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
59%
|
See Also
What is Henan Lingrui Pharmaceutical Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
-436.2m
CNY
Based on the financial report for Sep 30, 2023, Henan Lingrui Pharmaceutical Co Ltd's Cash from Investing Activities amounts to -436.2m CNY.
What is Henan Lingrui Pharmaceutical Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-9%
Over the last year, the Cash from Investing Activities growth was -111%. The average annual Cash from Investing Activities growth rates for Henan Lingrui Pharmaceutical Co Ltd have been -24% over the past three years , and -9% over the past ten years .